Mperia Therapeutics Inc

📍 Montreal, Canada🗓 Founded 2016👥 1 employees💰 Last funded Oct 2018
Mperia Therapeutics is the CD36 Therapeutics Development Company. Lead candidates applied to macrophage-driven inflammation via CD36 receptor immuno-metabolism mediation. Showing clear efficacy in pre-clinical models for dry age-related macular degeneration (dry AMD), atherosclerosis and NASH.
5
Total investors
5
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
Canada
5
Investor activity2016–2018 · investors recorded per year
2016220183
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Mperia Therapeutics Inc?
Mperia Therapeutics Inc has 5 investors on record on gritt.io, including 5 early-stage backers.
When did Mperia Therapeutics Inc last raise funding?
The most recent investment in Mperia Therapeutics Inc recorded on gritt.io was in October 2018.
When was Mperia Therapeutics Inc founded?
Mperia Therapeutics Inc was founded in 2016.
What industry is Mperia Therapeutics Inc in?
Mperia Therapeutics Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Mperia Therapeutics Inc based?
Mperia Therapeutics Inc is headquartered in Montreal, Canada.